CD86 and colitis: The results showed that PF decreased mature DC counts in the TNBS-induced colitis model and reduced the percentage of MHC-II+CD86+ DCs and the expression of IL-12 in vitro and in vivo, which means that PF can inhibit DC maturation from imDCs.